γ-interferon-induced resistance to 1,25-(OH)2 D3 in human monocytes and macrophages: A mechanism for the hypercalcemia of various granulomatoses

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 7, 1997, Pages 2222-2232

  Dusso, A S ^a   Kamimura, S ^a   Gallieni, M ^a   Zhong, M ^a   Negrea, L ^a   Shapiro, S ^a   Slatopolsky, E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; GAMMA INTERFERON; MESSENGER RNA; OXYGENASE; VITAMIN D RECEPTOR;

ARTICLE; CONTROLLED STUDY; GRANULOMATOSIS; HUMAN; HUMAN CELL; HYPERCALCEMIA; MACROPHAGE ACTIVATION; MONOCYTE; PRIORITY JOURNAL; VITAMIN D METABOLISM;

CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERFERON TYPE II; MACROPHAGES; MONOCYTES; RECEPTORS, CALCITRIOL; RNA, MESSENGER; STEROID HYDROXYLASES; TIME FACTORS; VITAMIN D;

EID: 0030839837     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.7.2222     Document Type: Article

References (57)

1. Dusso A, Brown A, Slatopolsky E. 1994 Extrarenal production of calcitriol. Semin Nephrol. 14:144-155.
2. Walters MR. 1992 Newly identified actions of the vitamin D endocrine system. Endocr Rev. 13:719-764.
3. Brown A, Dusso A, E. Slatopolsky. 1992 Vitamin D. In: Seldin DW, Geibish G, eds. The kidney: physiology and pathophysiology. pp 1505-1551.
4. 3. Application to hypervitaminosis D. J Cin Invest. 58:61-70.
5. 3. QJ Med. 53:165-180.
6. Adams JS, Gacad MA, Andres A, Endres DE, Sharma OP. 1986 Biochemical indicators of disordered vitamin D and calcium homeostasis in sarcoidosis. Sarcoidosis. 3:1-6.
7. Lambert PW, Stern PH, Avioli RC, et al. 1982 Evidence for extrarenal production of 1α,25-dihydroxyvitamin D in man. J Clin Invest. 69:722-725.
8. Gkonos PJ, London R, Hendler ED. 1984 Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end stage renal disease and active tuberculosis. N Engl J Med. 311:1683-1685.
9. 3 in a patient with rheumatoid arthritis. J Bone Miner Res. 1:221-226.
10. 3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis J Clin Endocrinol Metab. 65:1201-1209.
11. 3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med. 161:755-765.
12. Dusso AS, Finch J, Brown A, et al. 1991 Extrarenal production of calcitriol in normal and uremic humans. J Clin Endocrinol Metab. 72:157-164.
13. Gallieni M, Kamimura S, Ahmed A, et al. 1995 Kinetics of monocyte 1-hydroxylase in chronic renal failure. Am J Physiol. 268:F746-F753.
14. Halloran BP, Castro ME. 1989 Vitmin D kinetics in vivo: effect of 1,25-dihydroxyvitamin D administration. Am J Physiol. 256:E686-E691.
15. 3 through C-24 oxidation pathway. Biochemistry. 28:11763-1769.
16. 3 to calcitriol acid. Evidence for a pathway in kidney and bone involving 24-oxidation. Biochem J. 262:173-180.
17. 3 inducible catabolism of vitamin D metabolites in mouse intestine. Am J Physiol. 258:1763-1769.
18. 3 24-hydroxylase cytochrome P450 messenger ribonucleic acid levels in primary cultures of rat renal cells. Endocrinology. 132:1782-1788.
19. 3. FEBS. 327:13-16.
20. 3. J Nutr. 125:16905-16945.
21. Pryke AM, Duggan C, White CP, Posen S, Mason RS. 1990 Tumor necrosis factor a induces vitamin D-1-hydroxylase activity in normal human alveolar macrophages. J Cell Physiol. 142:652-656.
22. 3. J Bone Miner Res. 1:65 (Abstract).
23. 3 in normal human monocytes. J Biol Chem. 270:22160-22166.
24. 3 by normal human peripheral monocytes. Endocrinology. 133:2719-2723.
25. Yam LT, Li CY. 1971 Cytochemical identification of monocytes and granulocytes. J Pathol. 55:91-98.
26. Senior RM, Connolly NL, Cury JD, Welgus HG, Campbell EJ. 1989 Elastin degradation by human alveolar macrophages. A prominent role of metalloproteinase activity. Am Rev Respir Dis. 139:1251-1256.
27. Shapiro SD, Campbell EJ, Kobayashi DK, Welgus HG. 1990 Immune modulation of metalloproteinase production in human macrophages. Selective translational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. J Clin Invest. 96:1204:1210.
28. Tsuchiya S, Kobayashi Y, Goto Y, et al. 1982 Induction of maturation in cultured human monocytic leukemia cells by phorbol diester. Cancer Res. 42:1530-1536.
29. Burgos-Trinidad M, Brown AJ, DeLuca HF. 1990 A rapid assay for 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D24-hydroxylase. Anal Biochem. 190:102-107.
30. 3-24-hydroxylase, a multicatalytic enzyme. Biochemistry. 35:8465-8472.
31. 3 not requiring high performance liquid chromatography: applications to clinical studies. J Clin Endocrinol Metab. 58:91-98.
32. 3 and parameteres of disease activity. QJ Med. 54:269-281.
33. Adams JS, Modlin RL, Diz MM, Barnes PF. 1989 Potentiation of the macrophage 25-hydroxyvitamin D-1-hydroxylation reaction by human tuberculous pleural effusion fluid. 1989 J Clin Endocrinol Metab. 69:457-460.
34. 3. Am J Physiol. 259:272-277.
35. Yoshizawa T, Hasanda Y, Uematsu Y, et al. 1996 Disruption of the vitamin D receptor (VDR) in the mouse. J Bone Miner Res. 11:5124 (Abstract).
36. Auwerx J. 1991 The human leukemia cell line THP-1:A multifacetted model for the study of monocyte-macrophage differentiation. Experientia. 47:22-31.
37. 3 mediated gene regulation in human B lymphocytes. J Biol Chem. 269:13437-13443.
38. Owen TA, Bortell R, Yocum SA, et al. 1990 Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription. Proc Natl Acad Sci USA. 87:9990-9994.
39. 3-24-hydroxylase in rat osteoblasts. Endocrinology. 134:1794-1799.
40. 3 in the intestinal calcium transport mechanism. Endocrinology. 111:1546-1551.
41. Zhao X, Feldman D. 1993 Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells. Endocrinology. 132:1808-1814.
42. Rizk-Rabin M, Zineb R, Zhor B, Garabedian M, Jana P. 1994 Synthesis of and response to 1,25-dihydroxycholecalciferol by subpopulations of murine epidermal keratinocytes. Evidence for a paracrine system for. 1:25-dihydroxycholecalciferol. J Cell Physiol. 159:131-141.
43. Insogna KL, Dreyer BE, Mitnick M, Ellison AF, Broadus AE. 1988 Enhanced production rate of 1,25-dihydroxyviamm D in sarcoidosis. J Clin Endocrinol Metab. 66:72-75.
44. Chen KS, DeLuca HF. 1995 Cloning of the human 1α,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim Biophys Acta. 1263:1-9.
45. 3 stimulated synthesis of bone gla protein in rat osteosarcoma cells by a pretranslational mechanism. Endocrinology. 127:588-594.
46. 3-stimulated bone gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanism. Endocrinology. 128:2577-2582.
47. Lian JB, Stein GS, Bortell R, Owen TA. 1991 Phenotype suppression: a postulated molecular mechanism for mediating the relationship of proliferation and differentiation by Fos/Jun interactions at AP-1 sites in steroid responsive promoter elements of tissue specific- genes. J Cell Biochem. 45:9-14.
48. 3 in rat intestinal epithelial cells. J Cell Biochem. 55:230-240.
49. 3 stimulated osteocalcin gene transcription by tumor necrosis factor-α: Structural determinants within the vitamin D response element. Endocrinology. 134:2524-2531.
50. Fernandez-Martin JL, Kurian S, Nanes MS. 1996 TNFα induces an intranuclear repressor that inhibits vitamin D and retinoid X receptor function. J Bone Miner Res. 11:S114 (Abstract).
51. Gordon S, Perry VH, Rabinowitz S, Chung LP, Rosen H. 1988 Plasma membrane receptors of the mononuclear phagocyte system. J Cell Sci. 9:1-26.
52. Rappolee DA, Werb Z. 1992 Macrophage derived growth factors. Curr Top MIcrob Immunol. 181:87-140.
53. Trinchieri G, Perussia B. 1985 Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today. 6:131-136.
54. Romeo G, Fiorucci G, Rossi GB. 1989 Interferons in cell growth and development. Trend Genet. 5:19-24.
55. 3. J Cell Biochem. 49:26-31.
56. 3 and the regulation of macrophage function. Calcif Tissue Int. 33:673-676.
57. Yang S, Smith C, Prahl JM, Luo X, DeLuca HF. 1993 Vitamin D rickets suppresses cell mediated immunity in vivo. Arch Biochem Biophys. 303:98-106.